Press Releases

Advanced Search
  • Aug 13, 2019
    -- Preparing to file first IND in September 2019

    Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...

  • Aug 7, 2019
    - Conference Call with Live Audio Webcast on Tuesday August 13th at 9:00 AM ET -

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...

  • May 14, 2019
    - Preparing to file first IND in Q3 2019

    Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...

  • May 8, 2019
    - Conference Call with Live Audio Webcast on Tuesday May 14th at 9:00 AM ET -

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...

  • Mar 28, 2019
    - Pre-clinical and human compassionate use clinical evidence support IND filing mid-year 2019

    Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...

Show 5102550100 per page